A224060 Share Price Performance
₩2,995.00
-1970.00 (-39.68%)
Price ₩2,995.00
Share Price₩2,995.00
A224060 Community Narratives
There are no narratives available yet.
Recent A224060 News & Updates
No updates
THE CODI Co.,LTD. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -869.47
- Gross Margin
- 13.19%
- Net Profit Margin
- -12.80%
- Debt/Equity Ratio
- 229.4%
THE CODI Co.,LTD. Competitors
About A224060
- Founded
- 1999
- Employees
- 41
- CEO
- WebsiteView website
THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agent for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. The company was formerly known as CODI-M Co., LTD. and changed its name to THE CODI Co.,LTD. in November 2022. THE CODI Co.,LTD. was founded in 1999 and is headquartered in Cheonan-si, South Korea.
South Korean Market Performance
- 7 Days: -1.1%
- 3 Months: 22.2%
- 1 Year: 23.5%
- Year to Date: 30.6%
Over the last 7 days, the market has dropped 1.1%, driven by a decline of 5.7% in the Materials sector. In the last year, the market is actually up 24%. Looking forward, earnings are forecast to grow by 22% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading